Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Davies

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Archives of Biochemistry and Biophysics|November 10, 1995
The phosphorylation state of the cAMP response element binding protein is decreased in diabetic rat liverG F Davies, S M Crosson, R L Khandelwal, et al.
Diabetologia|November 24, 2001
Troglitazone selectively inhibits glyoxalase I gene expressionL Wu, E Eftekharpour, G F Davies, et al.
Biochemical Pharmacology|October 13, 2001
Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanismG F Davies, R L Khandelwal, L Wu, et al.
Journal of the American Podiatry Association|January 1, 1983
A survey of emergency room visits to determine the need for podiatric coverageG F Davies, S M Green, R J Kaplan, et al.
Cancer Letters|August 25, 2009
Troglitazone inhibits histone deacetylase activity in breast cancer cellsG F Davies, A R Ross, T G Arnason, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Archives of Biochemistry and Biophysics|November 10, 1995
The phosphorylation state of the cAMP response element binding protein is decreased in diabetic rat liverG F Davies, S M Crosson, R L Khandelwal, et al.
Diabetologia|November 24, 2001
Troglitazone selectively inhibits glyoxalase I gene expressionL Wu, E Eftekharpour, G F Davies, et al.
Biochemical Pharmacology|October 13, 2001
Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanismG F Davies, R L Khandelwal, L Wu, et al.
Journal of the American Podiatry Association|January 1, 1983
A survey of emergency room visits to determine the need for podiatric coverageG F Davies, S M Green, R J Kaplan, et al.
Cancer Letters|August 25, 2009
Troglitazone inhibits histone deacetylase activity in breast cancer cellsG F Davies, A R Ross, T G Arnason, et al.
Pageof 2